Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Xiyue Pharmaceutical is a prominent Chinese pharmaceutical manufacturer focused on the production of active pharmaceutical ingredients (APIs) and finished drug products. The company is a major global supplier of corticosteroids, including dexamethasone, prednisone, and hydrocortisone, which are essential for treating inflammatory and autoimmune diseases. Based in Xi'an, the company operates state-of-the-art, GMP-certified facilities and exports its products to numerous international markets. In addition to its core steroid portfolio, Shaanxi Xiyue produces a variety of vitamins, cardiovascular medications, and anti-infective drugs. It functions as a key subsidiary within the Shaanxi Pharmaceutical Holding Group, benefiting from large-scale industrial resources and state-backed infrastructure. The company's commitment to international quality standards has allowed it to maintain a significant presence in both domestic Chinese and global healthcare supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Xiyue Pharmaceutical.